Found: 55
Select item for more details and to access through your institution.
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0090-4
- By:
- Publication type:
- Article
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0089-x
- By:
- Publication type:
- Article
Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0093-1
- By:
- Publication type:
- Article
Author Correction: Selection and evaluation of an efficient method for the recovery of viral nucleic acids from complex biologicals.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0091-3
- By:
- Publication type:
- Article
Raman spectroscopy-based identification of toxoid vaccine products.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0088-y
- By:
- Publication type:
- Article
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0092-2
- By:
- Publication type:
- Article
Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0086-0
- By:
- Publication type:
- Article
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0084-2
- By:
- Publication type:
- Article
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0079-z
- By:
- Publication type:
- Article
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0083-3
- By:
- Publication type:
- Article
Publisher Correction: Augmented CD4<sup>+</sup> T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
VaxArray potency assay for rapid assessment of "pandemic" influenza vaccines.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0080-6
- By:
- Publication type:
- Article
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0057-5
- By:
- Publication type:
- Article
Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0065-5
- By:
- Publication type:
- Article
Generation of therapeutic antisera for emerging viral infections.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0082-4
- By:
- Publication type:
- Article
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0077-1
- By:
- Publication type:
- Article
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0071-7
- By:
- Publication type:
- Article
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0076-2
- By:
- Publication type:
- Article
System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0078-0
- By:
- Publication type:
- Article
An Ad/MVA vectored Theileria parva antigen induces schizont-specific CD8<sup>+</sup> central memory T cells and confers partial protection against a lethal challenge.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0073-5
- By:
- Publication type:
- Article
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0074-4
- By:
- Publication type:
- Article
Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0075-3
- By:
- Publication type:
- Article
A Plasmodium berghei sporozoite-based vaccination platform against human malaria.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0068-2
- By:
- Publication type:
- Article
Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0058-4
- By:
- Publication type:
- Article
Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0072-6
- By:
- Publication type:
- Article
Augmented CD4<sup>+</sup> T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0069-1
- By:
- Publication type:
- Article
AS03 stresses out macrophages: Commentary on 'Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties'.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0070-8
- By:
- Publication type:
- Article
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0063-7
- By:
- Publication type:
- Article
Selection and evaluation of an efficient method for the recovery of viral nucleic acids from complex biologicals.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0067-3
- By:
- Publication type:
- Article
Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0066-4
- By:
- Publication type:
- Article
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0064-6
- By:
- Publication type:
- Article
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0060-x
- By:
- Publication type:
- Article
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0062-8
- By:
- Publication type:
- Article
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0061-9
- By:
- Publication type:
- Article
Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0056-6
- By:
- Publication type:
- Article
Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Author Correction: Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0053-9
- By:
- Publication type:
- Article
A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0052-x
- By:
- Publication type:
- Article
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0050-z
- By:
- Publication type:
- Article
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0049-5
- By:
- Publication type:
- Article
Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0048-6
- By:
- Publication type:
- Article
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0051-y
- By:
- Publication type:
- Article
Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0046-8
- By:
- Publication type:
- Article
Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0043-3
- By:
- Publication type:
- Article
Obituary: Geoffrey Schild (1935–2017).
- Published in:
- 2018
- By:
- Publication type:
- Obituary
Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice